Addex Therapeutics Insider Trades

ADXN

Track insider trading activity from Addex Therapeutics executives and directors. See which insiders are buying and selling ADXN stock.

Trades Last 12 Months

ADXN Price

All Insider Trades for Addex Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dyer Timothy Mark CHIEF EXECUTIVE OFFICER
Holding Value $48.4M 16,848,979 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.6M 19,783,583 shares
$3.52
$2.87
Holding Value $0 0 shares
Last Trade
Sep 02, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.77M 1,638,639 shares
$3.52
$2.87
Kalinichev Mikhail HEAD OF TRANSLATIONAL SCIENCE
Holding Value $880k 306,765 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.78M 506,765 shares
$3.52
$2.87
Holding Value $7.2M 2,507,987 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.6M 3,009,085 shares
$3.52
$2.87
Manke Isaac Director
Holding Value $630k 219,561 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$949k 269,561 shares
$3.52
$2.87
Mills Roger CHIEF MEDICAL OFFICER
Holding Value $1.13M 393,139 shares
Last Trade
Sep 02, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.56M 442,837 shares
$3.52
$2.87
Holding Value $0 0 shares
Last Trade
Sep 02, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$949k 269,561 shares
$3.52
$2.87
Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER
Holding Value $1.73M 602,908 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$354k 100,485 shares
$3.52
$2.87

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up